These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20334725)

  • 21. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats.
    Gramsbergen JB; Cumming P
    Neurochem Int; 2007 Jul; 51(1):8-15. PubMed ID: 17475367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic unpredictable stress augments +3,4-methylenedioxymethamphetamine-induced monoamine depletions: the role of corticosterone.
    Johnson BN; Yamamoto BK
    Neuroscience; 2009 Apr; 159(4):1233-43. PubMed ID: 19409219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain.
    Colado MI; Camarero J; Mechan AO; Sanchez V; Esteban B; Elliott JM; Green AR
    Br J Pharmacol; 2001 Dec; 134(8):1711-23. PubMed ID: 11739248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists.
    Gudelsky GA; Yamamoto BK; Nash JF
    Eur J Pharmacol; 1994 Nov; 264(3):325-30. PubMed ID: 7698172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats.
    Stanley N; Salem A; Irvine RJ
    Neuroscience; 2007 Apr; 146(1):321-9. PubMed ID: 17306465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat.
    Nair SG; Gudelsky GA
    Brain Res; 2004 Jul; 1013(2):168-73. PubMed ID: 15193525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of extracellular serotonin and MDMA in the sensitizing effects of MDMA.
    van de Wetering R; Vorster JA; Geyrhofer S; Harvey JE; Keyzers RA; Schenk S
    Behav Brain Res; 2022 Jul; 430():113936. PubMed ID: 35605796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
    Freezer A; Salem A; Irvine RJ
    Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain.
    Darvesh AS; Yamamoto BK; Gudelsky GA
    J Pharmacol Exp Ther; 2005 Feb; 312(2):694-701. PubMed ID: 15456837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice.
    Trigo JM; Renoir T; Lanfumey L; Hamon M; Lesch KP; Robledo P; Maldonado R
    Biol Psychiatry; 2007 Sep; 62(6):669-79. PubMed ID: 17306775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating the relative reinforcing strength of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine.
    Wang Z; Woolverton WL
    Psychopharmacology (Berl); 2007 Jan; 189(4):483-8. PubMed ID: 17063335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum.
    Camarero J; Sanchez V; O'Shea E; Green AR; Colado MI
    J Neurochem; 2002 Jun; 81(5):961-72. PubMed ID: 12065608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential changes in mesolimbic dopamine following contingent and non-contingent MDMA self-administration in mice.
    Orejarena MJ; Berrendero F; Maldonado R; Robledo P
    Psychopharmacology (Berl); 2009 Aug; 205(3):457-66. PubMed ID: 19495729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerance to the locomotor-activating effects of 3,4-methylenedioxymethamphetamine (MDMA) predicts escalation of MDMA self-administration and cue-induced reinstatement of MDMA seeking in rats.
    Ball KT; Slane M
    Behav Brain Res; 2014 Nov; 274():143-8. PubMed ID: 25127684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice.
    Escobedo I; O'Shea E; Orio L; Sanchez V; Segura M; de la Torre R; Farre M; Green AR; Colado MI
    Br J Pharmacol; 2005 Jan; 144(2):231-41. PubMed ID: 15665862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-exposure to (+/-)3,4-methylenedioxy-methamphetamine (MDMA) facilitates acquisition of intravenous cocaine self-administration in rats.
    Fletcher PJ; Robinson SR; Slippoy DL
    Neuropsychopharmacology; 2001 Aug; 25(2):195-203. PubMed ID: 11425503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous administration of ecstasy (3,4-methylendioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo.
    Acquas E; Marrocu P; Pisanu A; Cadoni C; Zernig G; Saria A; Di Chiara G
    Eur J Pharmacol; 2001 Apr; 418(3):207-11. PubMed ID: 11343691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of SCH 23390 on (+/-)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats.
    Daniela E; Brennan K; Gittings D; Hely L; Schenk S
    Pharmacol Biochem Behav; 2004 Apr; 77(4):745-50. PubMed ID: 15099919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT.
    Shankaran M; Yamamoto BK; Gudelsky GA
    Synapse; 2001 Apr; 40(1):55-64. PubMed ID: 11170222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.